Moderna and Merck recently finished a phase 2 trial for personalized mRNA vaccines for melanoma patients. The vaccine uses genetic material from a person’s tumor to develop a vaccine that teaches a person’s immune system to identify cells that match that tumor, attacking those cells before they have a chance to grow.
Indian American-led research from Penn Medicine and The Wistar Institute has been awarded a prestigious $11.7 million Specialized Programs of Research Excellence, or SPORE, grant from the National Cancer Institute.
Penn Medicine and Wistar awarded $11 7 million melanoma research grant indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Penn Medicine and Wistar awarded $11 7 million melanoma research grant upenn.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from upenn.edu Daily Mail and Mail on Sunday newspapers.
Penn Medicine and Wistar Institute receive $11 7 million grant to treat melanoma thedp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedp.com Daily Mail and Mail on Sunday newspapers.